Application of Quality by Design in API Process Development | AIChE

Other Sites & Tools

Technical Groups

Application of Quality by Design in API Process Development

Chair(s)

Tabora, J. E., Bristol-Myers Squibb

Co-chair(s)

Wang, F., Gilead Sciences

This session covers the application of Quality by Design (QbD) principles to the process development of pharmaceutical active ingredients (APIs) or drug substances (DS).

Presentations

3:15 PM
(343a) Improving the Robustness of a Pharmaceutical Crystallization Process
3:40 PM
(343b) Development of An API Micronization Design Space Using a Design of Experiments Approach
4:05 PM
(343c) Model Based Design of Experiments for Pharmaceutical Process Development
4:30 PM
(343d) Application of in-Situ Raman Spectroscopy in Monitoring the Dynamic Trends of Polymorphic Transformation and Hydrogenation Reaction
4:55 PM
(343e) Application of Combined Experimental and Modeling Approach to Understand pH Driven Reactive Crystallization
5:20 PM
(343f) Model Based Development and Validation of a Preparative Size Exclusion Chromatography Step

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

2013 AIChE Annual Meeting
AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00
Pharmaceutical Discovery, Development and Manufacturing Forum only
AIChE Members $100.00
Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $150.00

More Conference Links